Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

Clinical trial NCT05805631 · RECRUITING

Trial details

NCT number: NCT05805631
Sponsor: Taipei Veterans General Hospital, Taiwan
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Epidermal Growth Factor Receptor Leptomeningeal Metastasis

Start date: 2024-08-01
Primary completion: 2026-12-31
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.